NSE · Healthcare · Medical Distribution
EPS came in at 8.76 against a street estimate of 6.80 — a beat of 28.8%.
with an average price target of ₹1,844.40.
| Holder | Stake |
|---|---|
| Surbhi Singh(prasid Uno Family Trust) | 10.45% |
| Invesco India Aggressive Hybrid Fund | 4.31% |
| ICICI Prudential Pharma Healthcare and Diaganostics (P.H.D) Fund | 2.16% |
| Bank of India Flexi Cap Fund | 2.12% |
| Cif III Scheme I | 1.95% |
| Document | Date |
|---|---|
| Q1 FY27 earnings call ENTERO HEALTHCARE SOLUTIONS LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Consolidated revenue grew 38.2% year-on-year to INR 1,940 crores; like-for- | 2026-08-17 |
| Quarterly results · Q1 FY27 DOCUMENT SUMMARY: ENTERO HEALTHCARE SOLUTIONS LIMITED HEADLINE NUMBERS • No financial numbers provided in this document • Document references unaudit | 2026-08-10 |
| Investor presentation · Q1 FY27 ENTERO HEALTHCARE SOLUTIONS LIMITED – Q1FY27 SUMMARY HEADLINE NUMBERS • Revenue (Q1FY27): INR 1,940.5 crore, up 38.2% YoY (reported) and 40.0% YoY o | 2026-08-07 |
| Annual report FY2026 SUMMARY FOR RETAIL INVESTORS — ENTERO HEALTHCARE SOLUTIONS LIMITED --- HEADLINE NUMBERS • Revenue FY26: ₹6,591 crore (₹65,912 million consolidated) | 2026-07-27 |
| Q4 FY26 earnings call ENTERO HEALTHCARE SOLUTIONS LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • Full year FY26 revenue: INR 6,591 crores, growth 31.5% year-on-year on like | 2026-06-02 |
| Investor presentation · Q4 FY26 ENTERO HEALTHCARE SOLUTIONS LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • FY26 Revenue: INR 6,591 Cr (up 29.3% YoY); Q4FY26 Revenue: INR 1,910 Cr (u | 2026-05-25 |
| Quarterly results · Q4 FY26 ENTERO HEALTHCARE SOLUTIONS LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Revenue from operations FY2026: Rs 3,482.41 million (down from Rs 4,086.70 | 2026-05-25 |
| Q3 FY26 earnings call ENTERO HEALTHCARE SOLUTIONS LIMITED – Q3 FY26 SUMMARY HEADLINE NUMBERS • Q3 Revenue: INR1,707 crores – 26% year-on-year growth, 9% quarter-on-quarte | 2026-02-20 |
Readable in the app.
| Announcement | Date |
|---|---|
| Acquisition of Entero Healthcare Solutions Limited Entero Healthcare Solutions Limited has informed the Exchange about Acquisition | 2026-05-25 |
| Amalgamation/Merger of Entero Healthcare Solutions Limited announced Entero Healthcare Solutions Limited has informed the Exchange about Amalgamation/Merger | 2026-05-06 |
| Acquires 51.5% stake in Anand Chemiceutics Entero Healthcare Solutions Limited has announced the acquisition of a 51.5% majority stake in Anand Chemiceutics, a diagnostic and MedTech solutions provider. This is a strategic acquisitio | 2026-02-09 |
| Update on acquisition of another business entity Entero Healthcare Solutions Limited has informed the Exchange about Update on Acquisition | 2026-02-07 |
| Acquisition of Entero Healthcare Solutions Limited Entero Healthcare Solutions Limited has informed the Exchange about Acquisition | 2025-11-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Entero Healthcare Solutions Ltd. — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.